ANI Pharmaceuticals Inc (NASDAQ:ANIP) announced the launch of Carbamazepine Extended-Release Capsules in 100 mg, 200 mg, and ...
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg and 300 mg. ANI’s Carbamazepine Extended-Release ...
Affordable generic versions of Ozempic and Wegovy have quickly secured 20% of the Rs 1,600 crore weight-loss market following ...
Top insights from the latest market news from Friday, April 10, from The Motley Fool analysts on Team Rule Breakers and Team ...
The FDA approves Apotex Corp.'s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could ...
Standing in the drugstore aisle confused? We've got you covered. From daily pills to nasal sprays, allergists break down ...
In the early 2020s, interest in GLP-1 weight loss drugs exploded. Now, as we move deeper into the decade, a new buzzword is taking over: peptides.
First approved by the US FDA in 2014 for advanced skin cancer, Keytruda is now used globally for certain lung cancers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results